HSIF14 · House Subcommittee

Health Subcommittee

House Energy and Commerce Subcommittee on Health

Showing the 117th Congress (2021–2022). Back to the 119th Congress

1,379 bills referred in the 117th Congress

10,366 across the 13 Congresses on file, more in this Congress than in any other. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 107th to 119th

Members
34

Served in the 117th Congress

Meetings
27

Hearings and business meetings in the 117th Congress

Members, 117th Congress 34

Everyone listed on the subcommittee in the 117th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 117th Congress.

Hearings, markups and business meetings, newest first. In the 117th Congress.

KindSubjectStatusDate
Hearing“FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics”Rayburn House Office Building 2123
7 witnesses
  • Dr. Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Dr. Peter Marks, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
  • Dr. Cartier Esham, Chief Scientific Officer, Executive Vice President, Emerging Companies, Biotechnology Innovation Organization
  • David Gaugh, Senior Vice President, Sciences and Regulatory Affairs, Association for Accessible Medicines
  • Dr. Reshma Ramachandran, Physician-Fellow, Yale National Clinician Scholars Program, Chair, Doctors for America FDA Task Force
  • Juliana Reed, Executive Director, Biosimilars Forum
  • Dr. Lucy Vereshchagina, Vice President, Science and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America
RescheduledFeb 3, 2022
Hearing“The Future of Biomedicine: Translating Biomedical Research into Personalized Health Care"Rayburn House Office Building 2123
5 witnesses
  • Dr. Amy Abernethy, President of Clinical Studies Platforms, Verily Life Sciences
  • Dr. Atul Butte, Distinguished Professor and Director of the Bakar Computational Health Sciences Institute, UCSF and Chief Data Scientist, UC Health
  • Adolph Falcón, Executive Vice President, National Alliance for Hispanic Health
  • Dr. Leroy Hood, President, Institute for Systems Biology, Affiliate Professor of Immunology, University of Washington
  • Dr. Lloyd Minor, Dean, Stanford University School of Medicine
RescheduledDec 8, 2021
Hearing“The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances”Rayburn House Office Building 2123
4 witnesses
  • Mr. Kemp Chester, Assistant Director, Executive Office of the President, Office of National Drug Control Policy
  • Mr. Douglas Throckmorton, Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Ms. Nora Volkow, Director, National Institute on Drug Abuse, National Institutes of Health
  • Mr. Louis Milione, Principal Deputy Administrator, U.S. Drug Enforcement Agency
ScheduledDec 2, 2021
MarkupNine Health BillsRayburn House Office Building 2123ScheduledNov 4, 2021
Hearing“Caring for America: Legislation to Support Patients, Caregivers, and Providers”Rayburn House Office Building 2123
7 witnesses
  • Mr. Corey Feist, Founder, Dr. Lorna Breen Foundation
  • Ms. Lisa Harrison, President, National Association of County and City Health Officials (NACCHO)
  • Dr. Brooks Keel, President, Augusta University
  • Mr. Alan Levine, Executive Chairman, President, and CEO, Ballad Health
  • Dr. Jeanne Marrazzo, Board Member, Infectious Disease Division Chief, Infectious Disease Society of America (IDSA), University of Alabama at Birmingham
  • Ms. Stephanie Monroe, Director, Equity and Access, Executive Director, UsAgainstAlzheimer's, AfricanAmericansAgainstAlzheimer's
  • Dr. Victoria Wilburn, Assistant Professor, Occupational Therapy, IUPUI School of Health & Human Sciences
ScheduledOct 26, 2021
Hearing"Enhancing Public Health: Legislation to Protect Children and Families"Rayburn House Office Building 2123
7 witnesses
  • Dr. Raymond DuBois, Former President, American Association for Cancer Research
  • Dr. Donald Lloyd-Jones, President, American Heart Association
  • Ms. Ellyn Miller, President and Founder, Smashing Walnuts Foundation
  • The Honorable Rick Nolan, Former U.S. Representative (MN)
  • Dr. Jenny Radesky, Assistant Professor of Pediatrics, University of Michigan Medical School
  • Ms. Stacey Stewart, President and CEO, March of Dimes
  • Dr. Bruce Cassis, President, Academy of General Dentistry
ScheduledOct 20, 2021
Hearing"The Future of Biomedicine: Translating Biomedical Research into Personalized Health Care"Rayburn House Office Building 2123PostponedSep 9, 2021
Hearing“The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases”Rayburn House Office Building 2123
9 witnesses
  • Dr. Richard Hodes, Director, National Institute on Aging, National Institutes of Health
  • Dr. Walter Koroshetz, Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health
  • Dr. Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Dr. Jinsy Andrews, Director of Neuromuscular Clinical Trials, Neurological Institute of New York, Associate Professor of Neurology, Columbia University Vagelos College of Physicians and Surgeons
  • Ms. Kala Booth, Huntington’s Disease Caregiver and Patient
  • Dr. Merit Cudkowicz, Director, Sean M. Healy and AMG Center for ALS, Chief, Neurology Department, Massachusetts General Hospital, Julianne Dorn Professor of Neurology, Harvard Medical School
  • Dr. Cartier Esham, Executive Vice President, Emerging Companies, Senior Vice President, Science and Regulatory Affairs, Biotechnology Innovation Organization
  • Ms. Yvonne Latty, Caregiver
  • Mr. Brian Wallach, Co-Founder, I AM ALS
ScheduledJul 29, 2021

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredReportedBecame lawMeetings
119th2025–2026, sitting323535225
118th2023–2024301,296901335
117th2021–2022341,379391327
116th2019–202049795371036
115th2017–201834780491750
114th2015–201631773281436
113th2013–201431741131825
112th2011–2012286511360
111th2009–2010397462710—
110th2007–2008338922720—
109th2005–200632815922—
108th2003–200481746522—
107th2001–2002337171112—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.